Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 179.86M
December 31, 2025 210.31M
June 30, 2025 205.34M
December 31, 2024 179.08M
June 30, 2024 173.09M
December 31, 2023 161.59M
June 30, 2023 124.85M
December 31, 2022 108.07M
June 30, 2022 97.33M
December 31, 2021 78.57M
June 30, 2021 69.27M
December 31, 2020 93.44M
June 30, 2020
December 31, 2019
June 30, 2019
December 31, 2018
June 30, 2018
December 31, 2017
June 30, 2017
December 31, 2016
June 30, 2016
December 31, 2015
June 30, 2015
December 31, 2014
Date Value
June 30, 2014
December 31, 2013
June 30, 2013
December 31, 2012
June 30, 2012
December 31, 2011
June 30, 2011
December 31, 2010
June 30, 2010
December 31, 2009
June 30, 2009
December 31, 2008
June 30, 2008
December 31, 2007
June 30, 2007
December 31, 2006
June 30, 2006
December 31, 2005
June 30, 2005
December 31, 2004
June 30, 2004
December 31, 2003
June 30, 2003
December 31, 2002 28.89M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
AstraZeneca PLC 14.54B
ANI Pharmaceuticals, Inc. 189.47M
Corcept Therapeutics, Inc. 109.70M
Veru, Inc. -26.04M
Avadel Pharmaceuticals Plc 37.01M